COVID VACCINE INVESTING. Up to date information about the smaller bio-pharmaceutical companies developing a COVID vaccine. This blog features a COVID INVESTOR INDEX which keeps track of the relative performance of 28 key COVID VACCINE companies.
Saturday 19 June 2021
Tough week for Novavax and rest of the TOP TEN - except Altimmune
Real Tough week for the TOP TEN. Only Altimmune picked up ground. Novavax's return falls 221% down to 990%.
Total return falls back under 200% - down to 197%.
No comments:
Post a Comment